A detailed history of Lecap Asset Management LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Lecap Asset Management LTD holds 1,346 shares of UTHR stock, worth $501,909. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,346
Holding current value
$501,909
% of portfolio
0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$311.04 - $363.55 $418,659 - $489,338
1,346 New
1,346 $482 Million
Q1 2024

Apr 25, 2024

BUY
$210.76 - $249.51 $213,078 - $252,254
1,011 Added 71.15%
2,432 $559 Million
Q4 2023

Jan 29, 2024

BUY
$214.88 - $256.94 $305,344 - $365,111
1,421 New
1,421 $312 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Lecap Asset Management LTD Portfolio

Follow Lecap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lecap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lecap Asset Management LTD with notifications on news.